amlodipine and ramiprilat

amlodipine has been researched along with ramiprilat in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (53.85)	18.2507
2000's	6 (46.15)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hintze, TH; Zhang, X	1
Bernstein, R; Hintze, TH; Nasjletti, A; Recchia, FA; Xu, X; Zhang, X	1
Doe, CP; Flynn, DM; Forfia, PR; Hintze, TH; Knight, DR; Smith, AH; Wolfgang, EA; Wolin, MS; Zhang, X	1
Hintze, TH; Kaley, G; Kichuk, MR; Michler, R; Mital, S; Nasjletti, A; Oz, M; Zhang, X	1
Addonizio, L; Bernstein, R; Hintze, TH; Kaley, G; Laycock, SK; Loke, KE; Mital, S; Oz, M; Wolin, MS	1
Carretero, OA; Curran, CM; Hintze, TH; Laycock, SK; Loke, KE; Messina, EJ; Shesely, EG	1
Hintze, TH; Nasjletti, A; Xu, X; Zhang, X	1
Addonizio, L; Gersony, WM; Hintze, TH; Loke, KE; Mital, S; Slater, JP	1
Hintze, TH; Loke, KE; Messina, EJ; Mital, S	1
Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG	1
Adler, S; Hintze, TH; Huang, H; Laumas, A; Loke, K; Xu, X	1
Adler, S; Gupta, S; Hintze, TH; Huang, H; Trochu, JN; Xu, X	1
Campestrini, J; Dole, K; Dole, WP; He, YL; Howard, D; Ligueros-Saylan, M; Marion, A; Pommier, F; Sabo, R; Sunkara, G; Wang, Y; Zhao, C	1

Trials

1 trial(s) available for amlodipine and ramiprilat

Article	Year
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects. Journal of clinical pharmacology, 2008, Volume: 48, Issue:1 Topics: Adamantane; Administration, Oral; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Half-Life; Headache; Humans; Male; Middle Aged; Nausea; Nitriles; Pyrrolidines; Ramipril; Tablets; Tetrazoles; Valine; Valsartan; Vildagliptin	2008

Article

Year

Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.

Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

Topics: Adamantane; Administration, Oral; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Half-Life; Headache; Humans; Male; Middle Aged; Nausea; Nitriles; Pyrrolidines; Ramipril; Tablets; Tetrazoles; Valine; Valsartan; Vildagliptin

2008

Other Studies

12 other study(ies) available for amlodipine and ramiprilat

Article	Year
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation, 1998, Feb-17, Volume: 97, Issue:6 Topics: Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Dogs; Dose-Response Relationship, Drug; Enalaprilat; In Vitro Techniques; Male; Nitric Oxide; Ramipril; Regression Analysis	1998
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:2 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Coronary Vessels; Cysteine Proteinase Inhibitors; Dogs; Enalaprilat; Glycopeptides; Heart Failure; Kininogens; Kinins; Nitric Oxide; Protease Inhibitors; Ramipril; Receptor, Bradykinin B2; Thiorphan; Vasodilator Agents	1999
NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine. The American journal of physiology, 1999, Volume: 276, Issue:6 Topics: Amlodipine; Animals; Bradykinin; Calcium Channel Blockers; Enzyme Inhibitors; Female; Hemodynamics; In Vitro Techniques; Macaca fascicularis; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxygen Consumption; Penicillamine; Ramipril; S-Nitroso-N-Acetylpenicillamine	1999
Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts. The American journal of cardiology, 1999, Aug-19, Volume: 84, Issue:4A Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin Receptor Antagonists; Calcium Channel Blockers; Cardiac Output, Low; Coronary Vessels; Dose-Response Relationship, Drug; Glycopeptides; Humans; Metalloendopeptidases; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Quinine; Ramipril; Serine Proteinase Inhibitors; Thiorphan	1999
Nitric oxide modulates mitochondrial respiration in failing human heart. Circulation, 1999, Sep-21, Volume: 100, Issue:12 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Calcium Channel Blockers; Humans; In Vitro Techniques; Mitochondria, Muscle; Myocardium; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Oxygen Consumption; Ramipril; Thiorphan; Vasodilator Agents	1999
Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 1 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Drug Interactions; Enzyme Inhibitors; Female; Heart; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen Consumption; Ramipril; Receptors, Bradykinin; Substance P	1999
Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels. Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:2 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Coronary Vessels; Coumarins; Dogs; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Kallikreins; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Ramipril	2000
Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. The American journal of cardiology, 1999, Jun-17, Volume: 83, Issue:12A Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Calcium Channel Blockers; Child; Coumarins; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Isocoumarins; Male; Middle Aged; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Penicillamine; Ramipril; Serine Proteinase Inhibitors	1999
Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamsters. Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:12 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Echocardiography; Enzyme Inhibitors; Kinins; Male; Mesocricetus; Muscles; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Organ Size; Oxygen; Oxygen Consumption; Penicillamine; Ramipril; Vasodilator Agents	2000
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine. Cardiovascular research, 2001, Volume: 49, Issue:1 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents	2001
Modulation of renal oxygen consumption by nitric oxide is impaired after development of congestive heart failure in dogs. Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:3 Topics: Amlodipine; Animals; Bradykinin; Cardiac Pacing, Artificial; Dogs; Female; Heart Failure; Kidney; Nitric Oxide; Nitric Oxide Donors; Oxygen Consumption; Ramipril	2001
Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure. American journal of physiology. Renal physiology, 2001, Volume: 281, Issue:5 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Dogs; Endothelium, Vascular; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Cortex; Kidney Medulla; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxygen Consumption; Penicillamine; Ramipril; Simvastatin; Ventricular Function, Left	2001